Iridex (IRIX) Stock: Buy, Sell, or Hold?
IRIX - Iridex Corp
$0.79
0.02 (2.89%)
â˛
5d:
-4.19%
30d:
+24.59%
90d:
-11.33%
WAIT
LOW Confidence
Analysis Updated: Oct 21, 2026 12:00 AM ET
Earnings: Nov 10, 2026
18d
Get Alerted When IRIX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: IRIX is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: IRIX is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: IRIX is currently trading at $0.79, which is considered slightly high relative to its 30-day fair value range of $0.62 to $0.82.
Technical Outlook: Technically, IRIX is in a strong downtrend. Immediate support is located at $0.75, while resistance sits at $0.98.
Market Sentiment: IRIX scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $2.75 (+258.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, IRIX is in a strong downtrend. Immediate support is located at $0.75, while resistance sits at $0.98.
Market Sentiment: IRIX scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $2.75 (+258.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$0.62 -
$0.82
Company Quality Score
28/100
(SELL)
Volume Confirmation
MODERATE
Confidence Score
36.8%
All Signals
- BEARISH: Weak technical setup (15/100)
- BULLISH: Trading 258.2% below Wall St target ($2.75)
- WARNING: Composite score 28/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.62 -
$0.82
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$0.75
Resistance Level
$0.98
Current Trend
Strong Downtrend
Technical data as of
Oct 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
769.23
Wall Street Target
$2.75
(+258.2%)
Revenue Growth (YoY)
-7.4%
Profit Margin
-6.9%
Share & Embed Analysis
Last updated: October 22, 2026 10:02 AM ET
Data refreshes hourly during market hours. Next update: 11:02 AM
Data refreshes hourly during market hours. Next update: 11:02 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IRIX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
31 analysts |
$59 | 50 HOLD |
|
SYK
Stryker Corporation |
STRONG BUY
29 analysts |
$363 | 37 SELL |
|
MDT
Medtronic PLC |
BUY
29 analysts |
$105 | 43 HOLD |
|
AXGN
Axogen Inc |
STRONG BUY
12 analysts |
$54 | 75 BUY |
|
TNDM
Tandem Diabetes Care Inc |
BUY
25 analysts |
$28 | 54 HOLD |
